CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
Recruiting · NCT07053488 · Registry updated 2025-07-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection | Digestive System Diseases, Digestive System Neoplasms, Fibrosis, Hepatic Insufficiency, Liver Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Steatohepatitis, cirrhosis of liver, fatty liver disease, liver cancer, liver disorder, liver failure, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-07-08 | NCT07053488 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University Health Science Center (PKUHSC) | Beijing | China | 2 |